Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia nabs CE Mark under IVDR for digital pathology platform

Proscia
By Author Proscia | June 8, 2022

Proscia announced it has obtained the CE Mark under IVDR, the new European in vitro diagnostic regulation, for use of its Concentriq Dx digital pathology platform in primary diagnosis.

Our website uses cookies. By using this site, you agree to its use of cookies.